Corcept Therapeutics (CORT) Short Interest Ratio & Short Volume → This TSLA short trade is on a nine win hot streak (From WealthPress) (Ad) Free CORT Stock Alerts $30.17 -1.04 (-3.33%) (As of 05/31/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Corcept Therapeutics Short Interest DataCurrent Short Interest19,800,000 sharesPrevious Short Interest19,800,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$551.03 millionShort Interest Ratio19.4 Days to CoverLast Record DateMay 15, 2024Outstanding Shares104,110,000 sharesFloat Size89,710,000 sharesShort Percent of Float22.07%Today's Trading Volume1,374,266 sharesAverage Trading Volume1,412,940 sharesToday's Volume Vs. Average97% Short Selling Corcept Therapeutics ? Sign up to receive the latest short interest report for Corcept Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCORT Short Interest Over TimeCORT Days to Cover Over TimeCORT Percentage of Float Shorted Over Time Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! Corcept Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202419,800,000 shares $551.03 million No Change22.1%19.4 $27.83 4/30/202419,800,000 shares $461.74 million -6.3%22.1%18 $23.32 4/15/202421,120,000 shares $488.93 million -1.0%23.7%17.5 $23.15 3/31/202421,330,000 shares $537.30 million +5.5%23.9%15 $25.19 3/15/202420,220,000 shares $469.71 million +1.8%22.7%13 $23.23 2/29/202419,860,000 shares $466.71 million +1.1%22.3%13.1 $23.50 Get the Latest News and Ratings for CORT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/202419,640,000 shares $480.39 million +1.7%22.0%13.4 $24.46 1/31/202419,320,000 shares $407.65 million +23.3%22.0%14.4 $21.10 1/15/202415,670,000 shares $363.54 million +1.8%17.8%13.2 $23.20 12/31/202315,390,000 shares $499.87 million +0.9%17.5%17 $32.48 12/15/202315,260,000 shares $453.99 million -0.8%17.4%19.6 $29.75 11/30/202315,380,000 shares $391.73 million +0.7%17.5%21.2 $25.47 11/15/202315,270,000 shares $387.55 million +8.1%17.4%20.6 $25.38 10/31/202314,120,000 shares $396.49 million -5.6%16.1%19.4 $28.08 10/15/202314,960,000 shares $412.30 million -0.1%17.1%20 $27.56 9/30/202314,970,000 shares $407.86 million +3.4%17.1%20.8 $27.25 9/15/202314,480,000 shares $484.65 million -2.2%16.6%24.1 $33.47 8/31/202314,800,000 shares $484.40 million -0.5%17.0%23.7 $32.73 8/15/202314,870,000 shares $460.38 million -1.3%17.1%23.9 $30.96 7/31/202315,070,000 shares $383.98 million -4.2%17.3%23.9 $25.48 7/15/202315,730,000 shares $358.96 million -1.1%18.2%27.3 $22.82 6/30/202315,910,000 shares $354.00 million -5.1%18.4%25.2 $22.25 6/15/202316,770,000 shares $388.90 million +0.2%19.2%21.6 $23.19 5/31/202316,730,000 shares $392.99 million -2.3%19.2%20.9 $23.49 5/15/202317,130,000 shares $412.15 million No Change19.6%19.2 $24.06 10/31/202217,050,000 shares $487.63 million -0.8%18.3%30.1 $28.60 10/15/202217,190,000 shares $467.91 million -0.8%18.6%30.8 $27.22 9/30/202217,330,000 shares $444.34 million +1.5%18.7%29.7 $25.64 9/15/202217,070,000 shares $431.87 million -1.6%18.5%26.7 $25.30 8/31/202217,350,000 shares $447.98 million -1.0%18.8%27 $25.82 8/15/202217,530,000 shares $492.07 million -2.2%19.0%25.6 $28.07 7/31/202217,930,000 shares $513.87 million +1.1%19.0%22.4 $28.66 7/15/202217,730,000 shares $482.97 million -1.8%18.8%21.5 $27.24 6/30/202218,060,000 shares $429.47 million -0.6%17.5%20.5 $23.78 6/15/202218,170,000 shares $383.39 million -5.6%17.6%19.8 $21.10 5/31/202219,240,000 shares $400.96 million -5.2%20.4%20.1 $20.84 5/15/202220,300,000 shares $384.48 million +12.0%21.5%20.6 $18.94 4/30/202218,130,000 shares $389.98 million +9.5%19.2%18.7 $21.51 4/15/202216,560,000 shares $405.55 million +2.8%17.6%17.5 $24.49 3/31/202216,110,000 shares $362.80 million -2.8%N/A18 $22.52This indicator is great for calling bottoms (Ad)“It was designed to help boost your chances of finding rock solid trade ideas” It’s called the “Master Indicator” And it’s quite possibly one of the most useful indicators you’ll ever use.If you’d like to join me just follow this link here. 3/15/202216,570,000 shares $397.68 million +2.3%17.6%16.7 $24.00 2/28/202216,200,000 shares $361.10 million -0.9%17.1%9.6 $22.29 2/15/202216,340,000 shares $331.87 million -10.2%17.2%9.5 $20.31 1/31/202218,190,000 shares $341.43 million -5.2%17.6%10.5 $18.77 1/15/202219,180,000 shares $353.87 million +13.3%18.5%11.3 $18.45 12/31/202116,930,000 shares $335.21 million -12.9%16.3%10.2 $19.80 12/15/202119,440,000 shares $375.19 million +116.0%18.8%12.5 $19.30 11/30/20219,000,000 shares $189 million +0.5%8.7%9.8 $21.00 11/15/20218,960,000 shares $205.09 million -2.9%8.7%14.8 $22.89 10/29/20219,230,000 shares $166.14 million +9.9%8.9%17.9 $18.00 10/15/20218,400,000 shares $168.34 million -0.7%8.1%17.2 $20.04 9/30/20218,460,000 shares $166.49 million +0.8%8.1%17.5 $19.68 9/15/20218,390,000 shares $171.41 million +1.0%8.1%17 $20.43 8/31/20218,310,000 shares $176.84 million +3.1%8.0%15.8 $21.28 8/13/20218,060,000 shares $166.68 million +2.3%7.7%15.2 $20.68 7/30/20217,880,000 shares $163.67 million +3.1%7.6%13.3 $20.77 7/15/20217,640,000 shares $155.55 million -5.2%7.3%13.6 $20.36 6/30/20218,060,000 shares $177.32 million -18.5%7.7%14.4 $22.00 6/15/20219,890,000 shares $216.89 million -2.9%9.4%17.8 $21.93 5/28/202110,180,000 shares $219.89 million +3.0%9.7%19.9 $21.60 5/14/20219,880,000 shares $206.69 million -1.7%9.4%17.7 $20.92 4/30/202110,050,000 shares $235.77 million -5.4%9.6%17.5 $23.46 4/15/202110,620,000 shares $243.73 million +1.4%N/A0 $22.95 3/31/202110,470,000 shares $245.94 million -2.9%9.9%18 $23.49 3/15/202110,780,000 shares $276.94 million -0.2%10.2%17.6 $25.69 2/26/202110,800,000 shares $276.05 million No Change10.2%16.5 $25.56 2/12/202110,800,000 shares $309.64 million -4.7%10.3%13.6 $28.67 1/29/202111,330,000 shares $325.28 million -4.1%10.9%12.9 $28.71 1/15/202111,810,000 shares $326.19 million -0.7%11.3%12.9 $27.62 12/31/202011,890,000 shares $311.16 million -7.7%11.4%12.9 $26.17 12/15/202012,880,000 shares $330.37 million -6.1%12.3%13.5 $25.65 11/30/202013,720,000 shares $315.42 million -17.1%13.1%11.2 $22.99 11/15/202016,540,000 shares $299.21 million -5.7%15.8%5.7 $18.09 10/30/202017,530,000 shares $300.81 million -6.7%16.7%6.4 $17.16 10/15/202018,780,000 shares $345.18 million -1.4%18.0%6.6 $18.38 9/30/202019,040,000 shares $331.39 million +1.0%18.3%6.7 $17.41 9/15/202018,860,000 shares $334.20 million -18.6%18.1%6.5 $17.72 8/31/202023,160,000 shares $294.13 million +2.8%22.2%8.3 $12.70 8/14/202022,520,000 shares $310.10 million +1.9%21.6%21.2 $13.77 7/31/202022,100,000 shares $330.40 million -1.3%21.2%20.7 $14.95 7/15/202022,380,000 shares $365.02 million -1.2%21.7%22.8 $16.31 6/30/202022,650,000 shares $380.97 million +1.9%21.9%23.2 $16.82 6/15/202022,230,000 shares $338.56 million +1.0%21.5%22 $15.23 5/29/202022,020,000 shares $333.38 million -0.4%21.3%20.4 $15.14 5/15/202022,100,000 shares $310.73 million +0.9%21.4%19.2 $14.06 4/30/202021,910,000 shares $277.38 million -0.3%21.2%19.1 $12.66 4/15/202021,980,000 shares $262.44 million +5.5%21.3%19.6 $11.94 3/31/202020,830,000 shares $273.71 million -5.7%20.2%18.8 $13.14 3/13/202022,084,400 shares $269.65 million +2.8%21.4%16.6 $12.21 2/28/202021,480,000 shares $225.54 million +0.3%20.8%23.7 $10.50This indicator is great for calling bottoms (Ad)“It was designed to help boost your chances of finding rock solid trade ideas” It’s called the “Master Indicator” And it’s quite possibly one of the most useful indicators you’ll ever use.If you’d like to join me just follow this link here. 2/14/202021,410,000 shares $242.79 million -6.6%19.8%23.4 $11.34 1/31/202022,910,000 shares $310.20 million +1.0%21.2%22.5 $13.54 1/15/202022,680,000 shares $313.44 million +3.1%21.0%23.2 $13.82 12/31/201922,000,000 shares $287.32 million +0.4%21.4%23.1 $13.06 8/15/201923,377,700 shares $292.46 million -4.4%22.6%33.8 $12.51 CORT Short Interest - Frequently Asked Questions What is Corcept Therapeutics' current short interest? Short interest is the volume of Corcept Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 19,800,000 shares of CORT short. 22.07% of Corcept Therapeutics' shares are currently sold short. Learn More on Corcept Therapeutics' current short interest. What is a good short interest ratio for Corcept Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CORT shares currently have a short interest ratio of 19.0. Learn More on Corcept Therapeutics's short interest ratio. Which institutional investors are shorting Corcept Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corcept Therapeutics: Walleye Trading LLC, Ikarian Capital LLC, Jane Street Group LLC, Kynam Capital Management LP, HAP Trading LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Corcept Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.07% of Corcept Therapeutics' floating shares are currently sold short. What is Corcept Therapeutics' float size? Corcept Therapeutics currently has issued a total of 104,110,000 shares. Some of Corcept Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corcept Therapeutics currently has a public float of 89,710,000 shares. How does Corcept Therapeutics' short interest compare to its competitors? 22.07% of Corcept Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Corcept Therapeutics: Axsome Therapeutics, Inc. (15.98%), Harmony Biosciences Holdings, Inc. (23.14%), Taro Pharmaceutical Industries Ltd. (0.91%), Xencor, Inc. (10.17%), OPKO Health, Inc. (26.01%), Atea Pharmaceuticals, Inc. (2.53%), ADC Therapeutics SA (1.36%), Jazz Pharmaceuticals plc (5.20%), Perrigo Company plc (3.08%), Supernus Pharmaceuticals, Inc. (9.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Corcept Therapeutics stock? Short selling CORT is an investing strategy that aims to generate trading profit from Corcept Therapeutics as its price is falling. CORT shares are trading down $1.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corcept Therapeutics? A short squeeze for Corcept Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CORT, which in turn drives the price of the stock up even further. How often is Corcept Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CORT, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Axsome Therapeutics Short Squeeze Harmony Biosciences Short Squeeze Taro Pharmaceutical Industries Short Squeeze Xencor Short Squeeze OPKO Health Short Squeeze Atea Pharmaceuticals Short Squeeze ADC Therapeutics Short Squeeze Jazz Pharmaceuticals Short Squeeze Perrigo Short Squeeze Supernus Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CORT) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWrite this ticker symbol down…StocksToTradeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.